2018. Brodalumab, a Human Anti-Interleukin-17 Receptor A Monoclonal Antibody, Shows Low Immunogenicity in Patients with Moderate-to-Severe Psoriasis. SKIN The Journal of Cutaneous Medicine. 2, S1 (Feb. 2018), S1. DOI:https://doi.org/10.25251/skin.2.supp.1.